An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author LUBIN, Jay H.
MUSCAT, Joshua
GAUDET, Mia M.
OLSHAN, Andrew F.
CURADO, Maria Paula
MASO, Luigino Dal
WUENSCH-FILHO, Victor
STURGIS, Erich M.
SZESZENIA-DABROWSKA, Neonilia
CASTELLSAGUE, Xavier
ZHANG, Zuo-Feng
SMITH, Elaine
FERNANDEZ, Leticia
MATOS, Elena
FRANCESCHI, Silvia
FABIANOVA, Eleonora
RUDNAI, Peter
PURDUE, Mark P.
MATES, Dana
WEI, Qingyi
HERRERO, Rolando
KELSEY, Karl
MORGENSTERN, Hal
SHANGINA, Oxana
KOIFMAN, Sergio
LISSOWSKA, Jolanta
LEVI, Fabio
DAUDT, Alexander W.
ELUF NETO, Jose FMUSP-HC
CHEN, Chu
LAZARUS, Philip
WINN, Deborah M.
SCHWARTZ, Stephen M.
BOFFETTA, Paolo
BRENNAN, Paul
MENEZES, Ana
VECCHIA, Carlo La
MCCLEAN, Michael
TALAMINI, Renato
RAJKUMAR, Thangarajan
HAYES, Richard B.
HASHIBE, Mia
dc.date.issued 2011
dc.identifier.citation CANCER CAUSES & CONTROL, v.22, n.9, p.1217-1231, 2011
dc.identifier.issn 0957-5243
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/23317
dc.description.abstract Greater tobacco smoking and alcohol consumption and lower body mass index (BMI) increase odds ratios (OR) for oral cavity, oropharyngeal, hypopharyngeal, and laryngeal cancers; however, there are no comprehensive sex-specific comparisons of ORs for these factors. We analyzed 2,441 oral cavity (925 women and 1,516 men), 2,297 oropharynx (564 women and 1,733 men), 508 hypopharynx (96 women and 412 men), and 1,740 larynx (237 women and 1,503 men) cases from the INHANCE consortium of 15 head and neck cancer case-control studies. Controls numbered from 7,604 to 13,829 subjects, depending on analysis. Analyses fitted linear-exponential excess ORs models. ORs were increased in underweight (< 18.5 BMI) relative to normal weight (18.5-24.9) and reduced in overweight and obese categories (a parts per thousand yen25 BMI) for all sites and were homogeneous by sex. ORs by smoking and drinking in women compared with men were significantly greater for oropharyngeal cancer (p < 0.01 for both factors), suggestive for hypopharyngeal cancer (p = 0.05 and p = 0.06, respectively), but homogeneous for oral cavity (p = 0.56 and p = 0.64) and laryngeal (p = 0.18 and p = 0.72) cancers. The extent that OR modifications of smoking and drinking by sex for oropharyngeal and, possibly, hypopharyngeal cancers represent true associations, or derive from unmeasured confounders or unobserved sex-related disease subtypes (e.g., human papillomavirus-positive oropharyngeal cancer) remains to be clarified.
dc.description.sponsorship · National Institutes of Health
· National Cancer Institute, Department of Health and Human Services
· National Institute of Environmental Health Sciences [P30ES10126]
dc.language.iso eng
dc.publisher SPRINGER
dc.relation.ispartof Cancer Causes & Control
dc.rights restrictedAccess
dc.subject Alcohol consumption; Cigarette smoking; Interactions; Odds ratio models
dc.subject.other body-mass index; human-papillomavirus infection; squamous-cell carcinoma; neck-cancer; oropharyngeal cancer; united-states; international head; inhance consortium; hpv infection; risk
dc.title An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies
dc.type article
dc.rights.holder Copyright SPRINGER
dc.description.group LIM/38
dc.identifier.doi 10.1007/s10552-011-9792-x
dc.identifier.pmid 21744095
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author ELUF NETO, Jose:FM:MPR
hcfmusp.author.external · LUBIN, Jay H.:NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
· MUSCAT, Joshua:Penn State Coll Med, Hershey, PA USA
· GAUDET, Mia M.:Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA
· OLSHAN, Andrew F.:Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
· CURADO, Maria Paula:Int Agcy Res Canc, F-69372 Lyon, France
· MASO, Luigino Dal:Aviano Canc Ctr, Epidemiol & Biostat Unit, I-33081 Aviano, Italy
· WUENSCH-FILHO, Victor:Univ Sao Paulo, Sao Paulo, Brazil
· STURGIS, Erich M.:UT MD Anderson Canc Ctr, Houston, TX USA
· SZESZENIA-DABROWSKA, Neonilia:Inst Occupat Med, Lodz, Poland
· CASTELLSAGUE, Xavier:CIBER ESP, IDIBELL, ICO, Barcelona, Spain
· ZHANG, Zuo-Feng:Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
· SMITH, Elaine:Univ Iowa, Coll Publ Hlth, Iowa City, IA USA
· FERNANDEZ, Leticia:Inst Oncol & Radiobiol, Havana, Cuba
· MATOS, Elena:Univ Buenos Aires, Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina
· FRANCESCHI, Silvia:Int Agcy Res Canc, F-69372 Lyon, France
· FABIANOVA, Eleonora:Specialized State Hlth Inst, Banska Bystrica, Slovakia
· RUDNAI, Peter:Natl Inst Environm Hlth, Budapest, Hungary
· PURDUE, Mark P.:NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
· MATES, Dana:Inst Publ Hlth, Dept Occupat Hlth, Bucharest, Romania
· WEI, Qingyi:UT MD Anderson Canc Ctr, Houston, TX USA
· HERRERO, Rolando:Inst Invest Epidemiol, San Jose, Costa Rica
· KELSEY, Karl:Brown Univ, Bio Med Ctr Environm Hlth & Technol, Providence, RI 02912 USA
· MORGENSTERN, Hal:Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
· SHANGINA, Oxana:Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia
· KOIFMAN, Sergio:Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil
· LISSOWSKA, Jolanta:M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; Inst Oncol, Warsaw, Poland
· LEVI, Fabio:Univ Lausanne, Inst Med Sociale & Prevent, Lausanne, Switzerland
· DAUDT, Alexander W.:Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
· CHEN, Chu:Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
· LAZARUS, Philip:Penn State Coll Med, Hershey, PA USA
· WINN, Deborah M.:NCI, Div Canc Control & Populat Sci, Rockville, MD 20852 USA
· SCHWARTZ, Stephen M.:Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
· BOFFETTA, Paolo:Int Agcy Res Canc, F-69372 Lyon, France; Mt Sinai Sch Med, New York, NY USA
· BRENNAN, Paul:Int Agcy Res Canc, F-69372 Lyon, France
· MENEZES, Ana:Univ Fed Pelotas, Pelotas, Brazil
· VECCHIA, Carlo La:Ist Ric Farmacol Mario Negri, Milan, Italy; Univ Milan, Milan, Italy
· MCCLEAN, Michael:Boston Univ, Sch Publ Hlth, Boston, MA USA
· TALAMINI, Renato:Aviano Canc Ctr, Epidemiol & Biostat Unit, I-33081 Aviano, Italy
· RAJKUMAR, Thangarajan:Canc Inst WIA, Dept Mol Oncol, Madras, Tamil Nadu, India
· HAYES, Richard B.:NYU, Langone Med Ctr, Div Epidemiol, New York, NY USA
· HASHIBE, Mia:Univ Utah, Huntsman Canc Inst, Dept Family & Prevent Med, Salt Lake City, UT USA
hcfmusp.origem.id WOS:000293296200001
hcfmusp.origem.id 2-s2.0-80052320500
hcfmusp.publisher.city DORDRECHT
hcfmusp.publisher.country NETHERLANDS
hcfmusp.relation.reference · AKIBA S, 1990, ENV HLTH PERSPECT, P8719
· Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960
· Altieri A, 2004, ORAL ONCOL, V40, P904, DOI 10.1016/j.oraloncology.2004.04.005
· Jung AC, 2010, INT J CANCER, V126, P1882, DOI 10.1002/ijc.24911
· Reimers N, 2007, INT J CANCER, V120, P1731, DOI 10.1002/ijc.22355
· Kreimer AR, 2006, INT J CANCER, V118, P2293, DOI 10.1002/ijc.21577
· Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217
· Markowitz LE, 2009, J INFECT DIS, V200, P1059, DOI 10.1086/604729
· Baris D, 2009, J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361
· Franceschi S, 2000, ORAL ONCOL, V36, P106, DOI 10.1016/S1368-8375(99)00070-6
· BLOT WJ, 1988, CANCER RES, V48, P3282
· Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979
· Muscat JE, 1996, CANCER RES, V56, P5192
· Bain C, 2004, J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143
· Gillison ML, 2008, J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025
· Rajkumar T, 2003, EUR J CANCER PREV, V12, P135, DOI 10.1097/01.cej.0000062796.86004.7c
· Paz IB, 1997, CANCER-AM CANCER SOC, V79, P595, DOI 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y
· Nilsson S, 2001, J EPIDEMIOL COMMUN H, V55, P825, DOI 10.1136/jech.55.11.825
· Lynch SM, 2009, AM J EPIDEMIOL, V170, P403, DOI 10.1093/aje/kwp134
· Hayes RB, 1999, CANCER CAUSE CONTROL, V10, P27, DOI 10.1023/A:1008876115797
· Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354
· Lubin JH, 2010, AM J EPIDEMIOL, V171, P1250, DOI 10.1093/aje/kwq088
· Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179
· Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051
· Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573
· KABAT GC, 1994, INT J EPIDEMIOL, V23, P1137, DOI 10.1093/ije/23.6.1137
· Herrero R, 2003, J NATL CANCER I, V95, P1772, DOI 10.1093/jnci/djg/107
· Gaudet MM, 2010, INT J EPIDEMIOL, V39, P1091, DOI 10.1093/ije/dyp380
· Ide R, 2008, ORAL DIS, V14, P314, DOI 10.1111/j.1601-0825.2007.01378.x
· Olshan AF, 2000, CANCER EPIDEM BIOMAR, V9, P185
· Tachezy R, 2005, ORAL DIS, V11, P181
· Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464
· Karagas MR, 2005, CANCER LETT, V219, P63, DOI 10.1016/j.canlet.2004.10.006
· Lubin JH, 2009, AM J EPIDEMIOL, V170, P937, DOI 10.1093/aje/kwp222
· Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x
· AXELSON O, 1978, SCAND J WORK ENV HEA, V4, P98
· BAIN C, 2004, J NATL CANCER I, V96, P1796
· Castelao JE, 2001, J NATL CANCER I, V93, P538, DOI 10.1093/jnci/93.7.538
· DAvanzo B, 1996, NUTR CANCER, V26, P219
· DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504
· Flegal KM, 2010, AM J EPIDEMIOL, V173, P1
· Franceschi S, 2001, ANN ONCOL, V12, P331, DOI 10.1023/A:1011191809335
· Freedman ND, 2007, BRIT J CANCER, V96, P1469, DOI 10.1038/sj.bjc.6603713
· FREEDMAN ND, 2007, CANCER
· GAIL MH, 1988, AM J IND MED, P13119
· Gallus S, 2003, CANCER EPIDEM BIOMAR, V12, P514
· Garavello W, 2006, ANN ONCOL, V17, P1459, DOI 10.1093/annonc/mdl166
· Hashibe M, 2000, INT J CANCER, V88, P129, DOI 10.1002/1097-0215(20001001)88:1<129::AID-IJC20>3.3.CO;2-L
· Hashibe M, 2002, CANCER CAUSE CONTROL, V13, P55, DOI 10.1023/A:1013991025848
· Henschke CI, 2004, LUNG CANCER-J IASLC, V43, P1, DOI 10.1016/j.lungcan.2003.08.024
· Jemal A, 2003, INT J CANCER, V105, P101, DOI 10.1002/ijc.11020
· MAYNE AT, 2006, CANC EPIDEMIOLOGY PR, P674
· Nieto A, 2003, BRIT J CANCER, V89, P1667, DOI 10.1038/sj.bjc.6601347
· Olshan AF, 2006, CANC EPIDEMIOLOGY PR, P627
· Perneger TV, 2001, J NATL CANCER I, V93, P1600, DOI 10.1093/jnci/93.21.1600
· Preston DL, 2006, EPICURE USERS GUIDE
· Puente D, 2006, CANCER CAUSE CONTROL, V17, P71, DOI 10.1007/s10552-005-0389-0
· Purdue MP, 2009, AM J EPIDEMIOL, V169, P132, DOI 10.1093/aje/kwn306
· Risch HA, 2002, J NATL CANCER I, V94, P308
· Silverman DT, 2006, CANC EPIDEMIOLOGY PR, P1101
· WACHOLDER S, 1991, CONTROL CLIN TRIALS, V12, P457, DOI 10.1016/0197-2456(91)90006-8
· Zang EA, 2002, J NATL CANCER I, V94, P308
dc.description.index MEDLINE
hcfmusp.citation.scopus 30
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Romênia
hcfmusp.affiliation.country Costa Rica
hcfmusp.affiliation.country Rússia
hcfmusp.affiliation.country Itália
hcfmusp.affiliation.country Espanha
hcfmusp.affiliation.country Estados Unidos
hcfmusp.affiliation.country Índia
hcfmusp.affiliation.country Suíça
hcfmusp.affiliation.country França
hcfmusp.affiliation.country Cuba
hcfmusp.affiliation.country Argentina
hcfmusp.affiliation.country Eslováquia
hcfmusp.affiliation.country Polônia
hcfmusp.affiliation.country Hungria


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics